GlassScriptPhysician profile
Brian Scott Mcmanus
NPI 1477089233
$7,884.14
in general payments reported to CMS, 2019-2025
23 companies · $1,534 in 2025
The $1,534 reported for 2025 was more than what 86% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $90.60 · 2022: $912 · 2023: $4,356 · 2024: $794 · 2025: $1,534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,547 · Travel and Lodging: $1,952 · Education: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,546.77 |
| Travel and Lodging | $1,951.86 |
| Education | $185.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,989.20 | 2023-2025 | Inspire |
| Medtronic, INC. | $1,495.42 | 2022-2023 | Stealthstation S8 Platform, Fusion, Nuvent |
| Acclarent, INC | $925.79 | 2022-2024 | Trudi Nav Cable, Acclarent Aera, Acclarent Navwire |
| Aerin Medical INC. | $860.13 | 2022-2024 | |
| Glaxosmithkline, LLC. | $626.58 | 2022-2025 | Nucala |
| Genzyme Corporation | $313.22 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $305.93 | 2023-2025 | Dupixent |
| Intersect Ent, INC. | $287.14 | 2019-2020 | |
| Integra Lifesciences Corporation | $187.40 | 2024-2025 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
| Optinose US, INC. | $174.31 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $151.98 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $131.44 | 2023 | |
| Stryker Corporation | $98.98 | 2022-2025 | Xpress Loprofile, Scopis Ent, Latera |
| Hikma Pharmaceuticals USA | $88.11 | 2023-2024 | Ryaltris |
| Smith+Nephew, INC. | $55.46 | 2022-2023 | Tula |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $55.14 | 2025 | |
| Itamar Medical INC | $29.00 | 2025 | Watchpatone |
| Phadia US INC. | $20.36 | 2024 | Immunocap |
| Paratek Pharmaceuticals, INC. | $18.80 | 2025 | Xhance |
| Baxter Healthcare | $18.28 | 2025 | Perclot |
| Merck Sharp & Dohme LLC | $18.07 | 2023 | |
| Lilly USA, LLC | $17.52 | 2025 | Zepbound, Mounjaro |
| Olympus America INC. | $15.88 | 2023 | Olympus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mcmanus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.